How much funding has MOMA Therapeutics raised?

MOMA Therapeutics has raised $236.0M in total funding, most recently a Series B round.

Who are MOMA Therapeutics's investors?

MOMA Therapeutics's investors include Third Rock Ventures, Goldman Sachs, Rock Springs Capital, Nextech Invest, Cormorant Asset Management, Casdin Capital.

When was MOMA Therapeutics founded?

MOMA Therapeutics was founded in 2020.

Where is MOMA Therapeutics headquartered?

MOMA Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is MOMA Therapeutics in?

MOMA Therapeutics operates in Biotech, Healthcare.

How many employees does MOMA Therapeutics have?

MOMA Therapeutics has 51-200 employees.

MOMA Therapeutics

Targeting the molecular machines of human disease

Cambridge, United States · Founded 2020 · $236.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: momatx.com
Total Funding: $236.0M
Last Round: $150.0M Series BMay 2022
Rounds: 2

About

MOMA Therapeutics is a clinical-stage precision medicine company dedicated to discovering the next generation of therapies by targeting highly dynamic molecular machines — a class of enzymes that underlie human disease. The company's platform focuses on small molecule drug discovery across oncology and other areas of significant unmet need, leveraging advances in genetics and functional genomics.

Summary

MOMA Therapeutics is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $236.0M in total across 2 rounds, most recently a $150.0M Series B round in May 2022. Investors include Third Rock Ventures, Goldman Sachs and Rock Springs Capital.

LinkedIn X (Twitter)